Differential-display polymerase chain reaction identifies nucleophosmin as an estrogen-regulated gene in human vascular smooth muscle cells

Purpose: Atheroprotective effects of estrogen (E 2) are well documented and are due in part to direct effects of E 2 on vascular cells. We recently demonstrated that human vascular smooth muscle cells (VSMCs) express a functional E 2 receptor capable of activating gene expression. This study was des...

Full description

Saved in:
Bibliographic Details
Published in:Journal of vascular surgery 1996-03, Vol.23 (3), p.477-482
Main Authors: Koike, Hideo, Karas, Richard H., Baur, Wendy E., O'Donnell, Thomas F., Mendelsohn, Michael E.
Format: Article
Language:English
Subjects:
Biological and medical sciences
Blood vessels and receptors
Cells, Cultured
Estrogens - genetics
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation - genetics
Humans
Immunoblotting
Muscle, Smooth, Vascular - chemistry
Muscle, Smooth, Vascular - physiology
Nuclear Proteins - analysis
Nuclear Proteins - genetics
Phosphoproteins - analysis
Phosphoproteins - genetics
Polymerase Chain Reaction - methods
RNA - isolation & purification
Sequence Analysis
Vertebrates: cardiovascular system
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose: Atheroprotective effects of estrogen (E 2) are well documented and are due in part to direct effects of E 2 on vascular cells. We recently demonstrated that human vascular smooth muscle cells (VSMCs) express a functional E 2 receptor capable of activating gene expression. This study was designed to identify E 2-regulated genes in human VSMCs. Methods: VSMC mRNA was screened by differential-display polymerase chain reaction (ddPCR) to identify E 2-regulated genes. Quiescent human VSMCs were stimulated with 10% fetal bovine serum in the absence or presence of 10 −8 mol/L E 2, and total cellular RNA was harvested. ddPCR was performed in triplicate on each RNA sample and differentially expressed candidate genes were isolated. Differential expression of candidate genes was confirmed by dot blotting, and positive bands were identified by sequence analysis. E 2-mediated regulation at the protein level was investigated by immunoblotting. Results: ddPCR of RNA harvested from aortic VSMCs identified a 462 bp gene product, EAo8, as a candidate E 2-regulated gene. Dot blotting with probes derived from four independent VSMC cultures demonstrated a 5.8±3.9-fold increase in EAo8 expression in response to E 2 treatment ( p
ISSN:0741-5214
1097-6809
DOI:10.1016/S0741-5214(96)80014-0